Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window
暂无分享,去创建一个
[1] C. Destache. ANTIMICROBIAL PHARMACODYNAMICS IN THEORY AND CLINICAL PRACTICE, 2ND EDITION , 2008 .
[2] S. Zinner,et al. In Vitro Dynamic Models as Tools to Predict Antibiotic Pharmacodynamics , 2007 .
[3] S. Zinner,et al. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. , 2006, The Journal of antimicrobial chemotherapy.
[4] O. Cars,et al. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. , 2006, The Journal of antimicrobial chemotherapy.
[5] P. McNamara,et al. Evolution of Ciprofloxacin-Resistant Staphylococcus aureus in In Vitro Pharmacokinetic Environments , 2004, Antimicrobial Agents and Chemotherapy.
[6] A. P. Arzamastsev,et al. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model. , 2004, The Journal of antimicrobial chemotherapy.
[7] S. Zinner,et al. Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination. , 2004, International journal of antimicrobial agents.
[8] Xilin Zhao,et al. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. , 2003, The Journal of antimicrobial chemotherapy.
[9] K. Drlica,et al. In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.
[10] K. Bowker,et al. Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model , 2003, Antimicrobial Agents and Chemotherapy.
[11] K. Bowker,et al. Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model , 2003, Antimicrobial Agents and Chemotherapy.
[12] Xilin Zhao,et al. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Musser,et al. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. , 2000, The Journal of infectious diseases.
[14] S. Zinner,et al. Inter- and Intraquinolone Predictors of Antimicrobial Effect in an In Vitro Dynamic Model: New Insight into a Widely Used Concept , 1998, Antimicrobial Agents and Chemotherapy.
[15] A. Firsov,et al. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model , 1997, Antimicrobial agents and chemotherapy.
[16] Apr Wilson,et al. Ciprofloxacin: 10 years of clinical experience , 1997 .